Key Insights

Highlights

Success Rate

81% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 42/100

Termination Rate

9.8%

5 terminated out of 51 trials

Success Rate

81.5%

-5.1% vs benchmark

Late-Stage Pipeline

25%

13 trials in Phase 3/4

Results Transparency

27%

6 of 22 completed with results

Key Signals

6 with results81% success

Data Visualizations

Phase Distribution

39Total
Not Applicable (10)
Early P 1 (1)
P 1 (6)
P 2 (9)
P 3 (7)
P 4 (6)

Trial Status

Completed22
Unknown12
Recruiting6
Terminated5
Not Yet Recruiting2
Withdrawn2

Trial Success Rate

81.5%

Benchmark: 86.6%

Based on 22 completed trials

Clinical Trials (51)

Showing 20 of 20 trials
NCT07851571Not ApplicableNot Yet Recruiting

Drone Transport of Deceased-Donor Kidney Grafts Between Two French Hospitals Before Transplantation: a Pilot Safety Study

NCT05907096Phase 2Active Not RecruitingPrimary

ARGX-117 in Deceased Donor Kidney Transplant Recipients at Risk for Delayed Graft Function

NCT07726134Not ApplicableRecruitingPrimary

The Impact of Intraoperative Diuretic Use on Delayed Graft Function Following Deceased Donor Renal Transplantation

NCT07825688Not ApplicableNot Yet RecruitingPrimary

TxAccess and Dd-cfDNA for Improved Care of Patients With Delayed Graft Function

NCT07020832Phase 3WithdrawnPrimary

Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Adults at High Risk of Delayed Graft Function (DGF) Following Kidney Allograft Transplantation

NCT03071536Not ApplicableCompleted

Furosemide Stress Test Predicting Early Graft Function in Kidney Transplantation

NCT06855758Not ApplicableActive Not Recruiting

Effect of Terlipressin for Intraoperative Blood Pressure Management in Kidney Transplantation

NCT06830798Phase 3RecruitingPrimary

Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney Transplantation

NCT04005469Phase 1Recruiting

Safety and Efficacy of Treprostinil (Remodulin®) In Reducing Ischemia-Reperfusion Injury During Kidney Transplantation

NCT07275632Phase 1RecruitingPrimary

The Effects of Vonoprazan Fumarate on DGF Incidence in DD Kidney Transplant Recipients

NCT02727296Phase 4CompletedPrimary

Volatile Anesthetic Protection Of Renal Transplants 2

NCT03829488Phase 3Completed

Better Evidence for Selecting Transplant Fluids

NCT06641622Completed

Study of the Correlation Between Donor CIRBP and Transplanted Kidney Function

NCT05513807Phase 3CompletedPrimary

Graft Acute Kidney Injury: Vitamin B3 to Facilitate Renal Recovery In the Early Life of a Transplant

NCT05430620Phase 3RecruitingPrimary

Intermittent Versus Continuous Surface O2 During HMP of DCD Kidneys

NCT06367205Not ApplicableRecruitingPrimary

Norepinephrine Infusion Combined With Goal-directed Fluid Therapy in Patients Undergoing Kidney Transplantations

NCT03864926Phase 4CompletedPrimary

Envarsus in Delayed Graft Function (E-DGF)

NCT05166460Not ApplicableUnknown

Novel Cooling Device for the Elimination of Warm Ischemia During Renal Transplantation

NCT02525510Not ApplicableCompleted

Deceased Organ Donor Interventions to Protect Kidney Graft Function

NCT00931255Phase 4Terminated

Tacrolimus to Sirolimus Conversion for Delayed Graft Function

Scroll to load more

Research Network

Activity Timeline